For the elucidation of functionally important DNA polymerase beta (polbeta) variant, we propose experiments to test a hypothesis of whether a defective repair gene, such as polbeta, has a contributory role in the increased disease risks such as toxicity and carcinogenesis. A deletion of 87 bp in the cDNA of polbeta, a base-excision repair (BER) gene, in primary colorectal, breast, and lung tumors was reported from this laboratory. We demonstrated expression of both wild-type (WT) and truncated polbeta (polbetadelta) proteins in tumors. We established a stable murine fibroblast cell line, 16.3deltaP that expresses endogenous mouse WT and transfected human polbetadelta proteins. The BER and DNA binding activities in 16.3deltaP cells were markedly reduced compared to 16.3 parent cells, expressing the WT polbeta. The 16.3deltaP cells are hypersensitive to MNNG and MNU. Data showed that the 16.3deltaP nuclear extract inhibits BER and DNA binding activities of nuclear extract made from 16.3 cells. These results suggest that the polbeta variant may interfere with the functions of WT enzyme and act as a dominant negative mutant. These observations led us to examine the mechanisms underlying the inhibitory role of the polbetadelta in the functions of WT enzyme. Therefore, in the goal of Specific Aim 1, we propose to investigate potential hypersensitivity of 16.3deltaP cells when DNA is damaged by MNU evaluated by survival, susceptibility to transformation, ability to form colonies in semisolid medium and tumorigenic potential. Next we will investigate, in Specific Aim 2, the in vitro effect of the polbetadelta protein on the sensitivities of the transgenic F1 mice exposed to MNU. The proposed experiments will establish F1 mouse lines expressing the polbetadelta under the control of a mammary epithelial specific whey acidic protein promoter. A potential increase in occurrence of tumors in Fl mice treated with MNU and differences in the biochemical functions of polbeta between tumors and matched control tissues will be determined.
In Specific Aim 3, we will elucidate a possible mechanism of dominant negative activity of the polbetadelta by evaluating interactions of the polbetadelta protein with XRCC1, poly (ADP- ribose) polymerase and AP endonuclease, three repair proteins. These studies have the potential to gain insight into mechanisms by which truncated polbeta interferes with the functions of WT polbeta and would have broader implications into increased susceptibility of individuals to develop related diseases, toxicity, teratogenesis, and carcinogenesis, following exposure to environmental agents.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA083768-01A1
Application #
6199375
Study Section
Chemical Pathology Study Section (CPA)
Program Officer
Okano, Paul
Project Start
2000-06-07
Project End
2004-05-31
Budget Start
2000-06-07
Budget End
2001-05-31
Support Year
1
Fiscal Year
2000
Total Cost
$233,100
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
017730458
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Rabi, Thangaiyan; Banerjee, Sipra (2009) Novel semisynthetic triterpenoid AMR-Me inhibits telomerase activity in human leukemic CEM cells and exhibits in vivo antitumor activity against Dalton's lymphoma ascites tumor. Cancer Lett 278:156-163
Rabi, Thangaiyan; Banerjee, Sipra (2008) Novel synthetic triterpenoid methyl 25-hydroxy-3-oxoolean-12-en-28-oate induces apoptosis through JNK and p38 MAPK pathways in human breast adenocarcinoma MCF-7 cells. Mol Carcinog 47:415-23
Wang, Liming; Bhattacharyya, Nandan; Rabi, Thangaiyan et al. (2007) Mammary carcinogenesis in transgenic mice expressing a dominant-negative mutant of DNA polymerase beta in their mammary glands. Carcinogenesis 28:1356-63
Wang, Liming; Bhattacharyya, Nandan; Chelsea, Diane M et al. (2004) A novel nuclear protein, MGC5306 interacts with DNA polymerase beta and has a potential role in cellular phenotype. Cancer Res 64:7673-7
Bhattacharyya, Nandan; Banerjee, Sipra (2003) Analysis of alterations in a base-excision repair gene in lung cancer. Methods Mol Med 74:413-38
Bhattacharyya, Nandan; Chen, Huan-Chao; Wang, Liming et al. (2002) Heterogeneity in expression of DNA polymerase beta and DNA repair activity in human tumor cell lines. Gene Expr 10:115-23
Bhattacharyya, N; Banerjee, T; Patel, U et al. (2001) Impaired repair activity of a truncated DNA polymerase beta protein. Life Sci 69:271-80
Bhattacharyya, N; Banerjee, S (2001) A novel role of XRCC1 in the functions of a DNA polymerase beta variant. Biochemistry 40:9005-13